Thomas J. O’Neill

2.6k total citations
54 papers, 2.0k citations indexed

About

Thomas J. O’Neill is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Thomas J. O’Neill has authored 54 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Immunology and 11 papers in Oncology. Recurrent topics in Thomas J. O’Neill's work include Immunotherapy and Immune Responses (8 papers), Metabolism, Diabetes, and Cancer (7 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Thomas J. O’Neill is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Metabolism, Diabetes, and Cancer (7 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Thomas J. O’Neill collaborates with scholars based in United States, Germany and United Kingdom. Thomas J. O’Neill's co-authors include Thomas A. Gustafson, Weimin He, Tibor Keler, Laura Vitale, Thomas C. Skalak, Gary K. Owens, Brian R. Wamhoff, Weimin He, Li-Zhen He and Jerrold M. Olefsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Thomas J. O’Neill

53 papers receiving 2.0k citations

Peers

Countries citing papers authored by Thomas J. O’Neill

Since Specialization

Citations

This map shows the geographic impact of Thomas J. O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. O’Neill more than expected).

Fields of papers citing papers by Thomas J. O’Neill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. O’Neill. The network helps show where Thomas J. O’Neill may publish in the future.

Co-authorship network of co-authors of Thomas J. O’Neill

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. O’Neill. A scholar is included among the top collaborators of Thomas J. O’Neill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. O’Neill. Thomas J. O’Neill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX ‐622 2025 ·Allergy ·Miles Murphy, Laura Vitale, Thomas J. O’Neill, Deena M. Maurer, (unknown), Andrea Crocker, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Russell A. Hammond, J. Goldstein, Lawrence J. Thomas, Tibor Keler, (unknown)	2
2	Reciprocal regulation of mTORC1 signaling and ribosomal biosynthesis determines cell cycle progression in activated T cells 2024 ·Science Signaling ·(unknown), (unknown), (unknown), (unknown), Thomas J. O’Neill, Daniel Krappmann, Tobias Straub, Jan Kranich, Reinhard Obst	3
3	TRAF6 controls T cell homeostasis by maintaining the equilibrium of MALT1 scaffolding and protease functions 2023 ·Frontiers in Immunology ·Thomas J. O’Neill, Andreas Gewies, Thomas Seeholzer, Daniel Krappmann	4
4	Dual targeting of mast cells and TSLP with a bispecific antibody 2023 ·The Journal of Immunology ·Diego Alvarado, Laura Vitale, Michael Murphy, Anna Wasiuk, Jenifer Widger, Andrea Crocker, (unknown), (unknown), Thomas J. O’Neill, (unknown), (unknown), (unknown), (unknown), Jay S. Lillquist, (unknown), (unknown), J. Goldstein, Lawrence J. Thomas, Henry C. Marsh, Tibor Keler	1
5	TPC1 deficiency or blockade augments systemic anaphylaxis and mast cell activity 2020 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Volodymyr Tsvilovskyy, Wiebke Nadolni, Andreas Breit, Thomas J. O’Neill, (unknown), Gunther Wennemuth, Christian Wahl‐Schott, Martin Biel, Christian Grimm, Marc Freichel, Thomas Gudermann, Norbert Klugbauer, Ingrid Boekhoff, Susanna Zierler	27
6	Evaluation of Outpatient Anticoagulation Bridging After Left Ventricular Assist Device Implantation 2020 ·Digital Commons-TMC (Texas Medical Center) ·(unknown), (unknown), (unknown), (unknown), Barbara Pisani, Thomas J. O’Neill, (unknown)	0
7	MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells 2019 ·Cell Reports ·Torben Gehring, Tabea Erdmann, (unknown), Carina Graß, Andrew Flatley, Thomas J. O’Neill, (unknown), Isabel Meininger, Özge Karayel, (unknown), Michael Grau, Hisaaki Shinohara, Katja Lammens, Regina Feederle, Stefanie M. Hauck, Georg Lenz, Daniel Krappmann	22
8	Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy 2018 ·Cancer Immunology Immunotherapy ·Laura Vitale, Lawrence J. Thomas, Li-Zhen He, Thomas J. O’Neill, Jenifer Widger, Andrea Crocker, Karuna Sundarapandiyan, James R. Storey, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), J. Goldstein, Henry C. Marsh, Tibor Keler	39
9	Thermally reversible nanoparticle gels with tuneable porosity showing structural colour 2017 ·Physical Chemistry Chemical Physics ·Zachary Ruff, Peter Cloetens, Thomas J. O’Neill, Clare P. Grey, Erika Eiser	4
10	Development of a Novel Antibody–Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1 2016 ·Molecular Cancer Therapeutics ·Lawrence J. Thomas, Laura Vitale, Thomas J. O’Neill, (unknown), Paul K. Wallace, Hans Minderman, (unknown), (unknown), (unknown), James R. Storey, (unknown), Russell A. Hammond, Jenifer Widger, Karuna Sundarapandiyan, Andrea Crocker, Henry C. Marsh, Tibor Keler	34
11	GRAF1 deficiency blunts sarcolemmal injury repair and exacerbates cardiac and skeletal muscle pathology in dystrophin-deficient mice 2015 ·Skeletal Muscle ·(unknown), Thomas J. O’Neill, Zhaokang Cheng, (unknown), Alexis R. Demonbreun, Jianbin Li, Xiao Xiao, Elizabeth M. McNally, Christopher P. Mack, Joan M. Taylor	14
12	Germline deletion of FAK-related non-kinase delays post-natal cardiomyocyte mitotic arrest 2012 ·Journal of Molecular and Cellular Cardiology ·Thomas J. O’Neill, Christopher P. Mack, Joan M. Taylor	6
13	Arteriolar Remodeling Following Ischemic Injury Extends from Capillary to Large Arteriole in the Microcirculation 2008 ·Microcirculation ·Alexander M. Bailey, Thomas J. O’Neill, (unknown), Shayn M. Peirce	32
14	Targeting antigens to the human mannose receptor expressed in transgenic mice elicits potent CD4 and CD8 responses in vivo 2006 ·Cancer Research ·Li-Zhen He, Andrea Crocker, Laura Vitale, Thomas J. O’Neill, Raphael Clynes, Tibor Keler	1
15	Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules 2004 ·The Journal of Immunology ·Venky Ramakrishna, Jack Treml, Laura Vitale, John E. Connolly, Thomas J. O’Neill, Patricia Smith, Charles Jones, Li-Zhen He, J. Goldstein, Paul K. Wallace, Tibor Keler, M. Endres	97
16	Interaction of MAD2 with the Carboxyl Terminus of the Insulin Receptor but Not with the IGFIR EVIDENCE FOR RELEASE FROM THE INSULIN RECEPTOR AFTER ACTIVATION 1997 ·Journal of Biological Chemistry ·Thomas J. O’Neill, (unknown), Thomas A. Gustafson	38
17	Interaction of a GRB-IR Splice Variant (a Human GRB10 Homolog) with the Insulin and Insulin-like Growth Factor I Receptors 1996 ·Journal of Biological Chemistry ·Thomas J. O’Neill, David W. Rose, Tahir S Pillay, Kikuko Hotta, Jerrold M. Olefsky, Thomas A. Gustafson	122
18	Interaction of Insulin Receptor Substrate-2 (IRS-2) with the Insulin and Insulin-like Growth Factor I Receptors 1996 ·Journal of Biological Chemistry ·Weimin He, (unknown), (unknown), Thomas J. O’Neill, Ling-Mei Wang, Jacalyn H. Pierce, Thomas A. Gustafson	111
19	Non-SH2 Domains within Insulin Receptor Substrate-1 and SHC Mediate Their Phosphotyrosine-dependent Interaction with the NPEY Motif of the Insulin-like Growth Factor I Receptor 1995 ·Journal of Biological Chemistry ·(unknown), Thomas J. O’Neill, Thomas A. Gustafson	140
20	Maturation of Human Immunodeficiency Virus Particles Assembled from the gag Precursor Protein Requires In Situ Processing by gag-pol Protease 1991 ·AIDS Research and Human Retroviruses ·Elizabeth K. Ross, Thomas R. Fuerst, Jan M. Orenstein, Thomas J. O’Neill, María Ángeles Martín, Sundararajan Venkatesan	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact